[
  {
    "ts": "2025-12-19T04:34:44+00:00",
    "headline": "2 Profitable Stocks to Consider Right Now and 1 We Turn Down",
    "summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
    "url": "https://finance.yahoo.com/news/2-profitable-stocks-consider-now-043444339.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "66cd3d1d-77de-382a-8621-ebca9e1bd7ae",
      "content": {
        "id": "66cd3d1d-77de-382a-8621-ebca9e1bd7ae",
        "contentType": "STORY",
        "title": "2 Profitable Stocks to Consider Right Now and 1 We Turn Down",
        "description": "",
        "summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
        "pubDate": "2025-12-19T04:34:44Z",
        "displayTime": "2025-12-19T04:34:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/6ba15e88b9e705b13607f60227d84762",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "SBUX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vCw4nl44f5RkzhcoLeXRdA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/6ba15e88b9e705b13607f60227d84762.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DCWpwoZdLiQh5Z06QA.5LA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/6ba15e88b9e705b13607f60227d84762.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-profitable-stocks-consider-now-043444339.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-profitable-stocks-consider-now-043444339.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SBUX"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T16:06:24+00:00",
    "headline": "Is Boston Scientific Still Attractive After Strong Multi Year Share Price Gains?",
    "summary": "If you are wondering whether Boston Scientific at around $96 a share is still a smart buy, or if most of the upside is already priced in, you are not alone. That is exactly what this breakdown will tackle. The stock has delivered a solid 108.7% return over the last 3 years and 177.9% over 5 years, even if the last month has been slightly softer at -0.9% after a 3.8% bounce in the past week. Recent headlines have focused on Boston Scientific expanding its minimally invasive cardiac and...",
    "url": "https://finance.yahoo.com/news/boston-scientific-still-attractive-strong-160624782.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "76c135c8-8b3a-3e20-a57f-ff1b37713740",
      "content": {
        "id": "76c135c8-8b3a-3e20-a57f-ff1b37713740",
        "contentType": "STORY",
        "title": "Is Boston Scientific Still Attractive After Strong Multi Year Share Price Gains?",
        "description": "",
        "summary": "If you are wondering whether Boston Scientific at around $96 a share is still a smart buy, or if most of the upside is already priced in, you are not alone. That is exactly what this breakdown will tackle. The stock has delivered a solid 108.7% return over the last 3 years and 177.9% over 5 years, even if the last month has been slightly softer at -0.9% after a 3.8% bounce in the past week. Recent headlines have focused on Boston Scientific expanding its minimally invasive cardiac and...",
        "pubDate": "2025-12-19T16:06:24Z",
        "displayTime": "2025-12-19T16:06:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-still-attractive-strong-160624782.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-still-attractive-strong-160624782.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T15:25:00+00:00",
    "headline": "PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial",
    "summary": "PLSE has secured FDA IDE approval to launch its nPulse AF ablation study.",
    "url": "https://finance.yahoo.com/news/plse-wins-fda-ide-approval-152500142.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5ebb4458-b936-3624-8020-58ead512c236",
      "content": {
        "id": "5ebb4458-b936-3624-8020-58ead512c236",
        "contentType": "STORY",
        "title": "PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial",
        "description": "",
        "summary": "PLSE has secured FDA IDE approval to launch its nPulse AF ablation study.",
        "pubDate": "2025-12-19T15:25:00Z",
        "displayTime": "2025-12-19T15:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/35df2d293bff824e6b9f2134b8f740a3",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rWMhRFFPXvxgHEXE2B1wdA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/35df2d293bff824e6b9f2134b8f740a3.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7wTUD3ufBzPmxbF02fBrHg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/35df2d293bff824e6b9f2134b8f740a3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/plse-wins-fda-ide-approval-152500142.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/plse-wins-fda-ide-approval-152500142.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]